Collegium Pharmaceutical (COLL) Current Assets (2014 - 2026)

Collegium Pharmaceutical's Current Assets history runs 13 years deep, the most recent figure standing at $745.7 million for Q1 2026.

• In Q1 2026, Current Assets rose 41.34% year-over-year to $745.7 million; the TTM figure through Mar 2026 stood at $745.7 million (up 41.34% YoY), while the FY2025 annual figure was $691.4 million, up 43.37% from the prior year.
• Current Assets was $745.7 million for Q1 2026 at Collegium Pharmaceutical, up from $691.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $745.7 million in Q1 2026 to a low of $363.6 million in Q1 2022.
• Historically, Current Assets has averaged $518.4 million across 5 years, with a median of $527.6 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Current Assets retreated 17.37% in 2024, then jumped 43.37% in 2025.
• A 5-year view of Current Assets shows it stood at $420.0 million in 2022, then grew by 28.0% to $537.6 million in 2023, then dropped by 10.29% to $482.3 million in 2024, then jumped by 43.37% to $691.4 million in 2025, then grew by 7.85% to $745.7 million in 2026.
• The last three Current Assets figures came in at $745.7 million (Q1 2026), $691.4 million (Q4 2025), and $613.9 million (Q3 2025), per Business Quant data.